Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic CellsRavi Bhatia(City Of Hope National Medical Center)Cancer ResearchDecember 1, 200810.1158/0008-5472.can-08-1131Cited by 99SaveCiteExport RISWatch citationsRelated PapersEffective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606|Blood|2007|105Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells|Blood|2007|59Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling|Leukemia|2022|30Low c-Kit expression identifies primitive, therapy-resistant CML stem cells|JCI Insight|2022|9